Yahoo
NasdaqCM - Nasdaq Real Time Price USD

LENSAR, Inc. (LNSR)

8.94 -0.29 (-3.14%)
At close: August 25 at 4:00:01 PM EDT
8.85 -0.09 (-1.00%)
Pre-Market: 4:50:05 AM EDT
Trade LENSAR on Coinbase
Chart Range Bar
Loading chart for LNSR
  • Previous Close 9.23
  • Open 9.17
  • Bid 6.48 x 100
  • Ask 11.40 x 200
  • Day's Range 8.85 - 9.25
  • 52 Week Range 4.95 - 12.94
  • Volume 92,481
  • Avg. Volume 116,825
  • Market Cap (intraday) 109.836M
  • Beta (5Y Monthly) 0.88
  • PE Ratio (TTM) 47.05
  • EPS (TTM) 0.19
  • Earnings Date Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 11.50

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

www.lensar.com

150

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 8/25/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LNSR
23.13%
S&P 500 (^GSPC)
12.15%

1-Year Return

LNSR
29.38%
S&P 500 (^GSPC)
19.23%

3-Year Return

LNSR
168.47%
S&P 500 (^GSPC)
74.26%

5-Year Return

LNSR
10.78%
S&P 500 (^GSPC)
70.75%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 13.43M
Earnings 36.33M
Profit Margin 270.57%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
10M
20M
30M
0.0%
100.0%
200.0%

Analyst Insights

View More

Analyst Price Targets

10.00
11.50 Average
8.94 Current
13.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/20/2026
Analyst BTIG
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 9 -> 10

Statistics

View More

Valuation Measures

Annual
As of 8/24/2026
  • Market Cap

    109.84M

  • Enterprise Value

    98.65M

  • Trailing P/E

    45.85

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.75

  • Price/Book (mrq)

    7.56

  • Enterprise Value/Revenue

    1.68

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    57.57%

  • Return on Assets (ttm)

    -18.66%

  • Return on Equity (ttm)

    357.30%

  • Revenue (ttm)

    60.26M

  • Net Income Avi to Common (ttm)

    14.7M

  • Diluted EPS (ttm)

    0.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.56M

  • Total Debt/Equity (mrq)

    8.30%

  • Levered Free Cash Flow (ttm)

    -24.39M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

8.94 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: